Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
暂无分享,去创建一个
Sigurdur Y Kristinsson | M. Björkholm | I. Turesson | S. Kristinsson | O. Landgren | M. McMaster | Ingemar Turesson | Ola Landgren | Magnus Björkholm | Mary L McMaster
[1] A. Rossi,et al. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Dimopoulos,et al. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece , 2002, Annals of Hematology.
[3] M. Björkholm,et al. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. , 2008, Blood.
[4] Stefan Boehringer,et al. Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. , 2006, American journal of human genetics.
[5] M. McMaster. Familial Waldenstrom's macroglobulinemia. , 2003, Seminars in oncology.
[6] G. Csako,et al. Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high‐risk phenotype in familial Waldenström macroglobulinemia , 2007, International Journal of Cancer.
[7] M. Tucker,et al. Long-term Evaluation of Three Multiple-Case Waldenström Macroglobulinemia Families , 2007, Clinical Cancer Research.
[8] J. Fraumeni,et al. Cancer epidemiology and prevention. , 2006 .
[9] U. Axelsson,et al. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. , 2009, Acta medica Scandinavica.
[10] M. Kraus,et al. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: one disease or three? , 2001, American journal of clinical pathology.
[11] Terry M Therneau,et al. Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.
[12] L. Melton,et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. , 2007, Mayo Clinic proceedings.
[13] Kenneth C. Anderson,et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group , 2003, British journal of haematology.
[14] K. Hemminki,et al. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. , 2004, Blood.
[15] J. Olsen,et al. Familial Aggregation and Heterogeneity of Non-Hodgkin Lymphoma in Population-Based Samples , 2005, Cancer Epidemiology Biomarkers & Prevention.
[16] J. Koshiol,et al. Chronic immune stimulation and subsequent Waldenström macroglobulinemia. , 2008, Archives of internal medicine.
[17] S. Strobel. Transient paraproteinemia: an intriguing immunological anomaly. , 2003, Annals of clinical and laboratory science.
[18] H. Cohen,et al. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. , 1998, The American journal of medicine.
[19] J. Fraumeni,et al. Waldenström's macroglobulinemia , 1998, Cancer.
[20] Terry M Therneau,et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.
[21] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[22] M. Vicariot,et al. Monoclonal gammopathies in the adult population of Finistère, France. , 1982, Journal of clinical pathology.
[23] H. El‐Serag,et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. , 2007, JAMA.
[24] T. Therneau,et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. , 2003, Seminars in oncology.
[25] M. Tomonaga,et al. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. , 2007, Mayo Clinic proceedings.